Physical PerformanceNCT07604090
Acute Effects of Fibular Repositioning Taping on Balance, Jumping, and Sprint Performance
A study testing Fibular Repositioning Taping in people with Physical Performance and Balance, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial aims to investigate the acute effects of fibular repositioning taping on balance, jumping, and sprint performance in healthy individuals. Eligible participants are randomly allocated to one of three groups: fibular repositioning taping, sham taping, or control. Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Physical Performance, Balance, Taping
- What is being tested?
- Fibular Repositioning Taping
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 90 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 2 Jan 2026to 15 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy individuals
- Age between 18 and 30 years
- Willingness to participate in the study and provide informed consent
- Ability to perform balance, jump, and sprint performance tests
Who cannot join
- History of lower extremity injury or surgery within the last 6 months
- Presence of acute pain during testing
- Neurological, orthopedic, or vestibular condition that may affect balance or performance
- Previous experience of adverse reaction to taping material
- Refusal to participate or inability to complete the study procedures
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Acute Effect of Fibular Repositioning Taping on Balance, Jumping, and Sprint Performance in Healthy Individuals: A Randomized Controlled Trial
This randomized controlled trial aims to investigate the acute effects of fibular repositioning taping on balance, jumping, and sprint performance in healthy individuals. Eligible participants are randomly allocated to one of three groups: fibular repositioning taping, sham taping, or control. Physical performance and dynamic balance are assessed at baseline and after the intervention using functional outcome measures, including jumping tests, a 10-meter sprint test, and the Y Balance Test. The study is designed to determine whether fibular repositioning taping produces short-term changes in selected performance parameters compared with sham taping and no intervention.
- Conditions
- Physical Performance, Balance, Taping
- Being tested
- Fibular Repositioning Taping, Sham Taping
- Keywords
- Fibular Repositioning Taping, Sprint Performance, Balance, Jumping Performance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fibular Repositioning TapingProcedure or surgery
Fibular repositioning taping is applied to the dominant ankle using a rigid taping technique intended to support fibular positioning. Outcome measurements are repeated 30 minutes after the application.
Sham TapingProcedure or surgery
Sham taping is applied to the dominant ankle with a similar appearance to the active taping application but without therapeutic fibular repositioning or manual correction
| Study group | Role | What they receive |
|---|---|---|
| Fibular Repositioning Taping Group | Experimental | Participants in this group receive fibular repositioning taping applied to the dominant ankle. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the intervention. Receives: Procedure: Fibular Repositioning Taping |
| Sham Taping Group | Sham comparator | Participants in this group receive a sham taping application with a similar appearance to the fibular repositioning taping but without therapeutic fibular repositioning. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the application. Receives: Procedure: Sham Taping |
| Control Group | No intervention | Participants in this group receive no taping intervention. Baseline assessments are performed, and outcome measurements are repeated after a 30-minute waiting period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Y Balance Test
Dynamic balance will be assessed using the Y Balance Test. The composite score will be calculated from reach distances and normalized to limb length. Higher composite scores indicate better dynamic balance performance.
Measured: Baseline and 30 minutes after the intervention
Horizontal Jump Test
Horizontal jump performance will be assessed using the Horizontal Jump Test. The jump distance will be measured in centimeters from the starting line to the landing point. Greater distance indicates better horizontal jump performance.
Measured: Baseline and 30 minutes after the intervention
10-Meter Sprint Test
Sprint performance will be assessed using the 10-meter sprint test. The time required to complete the 10-meter sprint will be recorded in seconds. Shorter times indicate better sprint performance.
Measured: Baseline and 30 minutes after the intervention
Vertical Jump Test
Vertical jump performance will be assessed using the Vertical Jump Test. Jump height will be measured in centimeters. Greater jump height indicates better vertical jump performance.
Measured: Baseline and 30 minutes after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start2 Jan 2026
- Primary completion15 May 2026
- Study completion15 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Physical PerformanceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Selim Mahmut GÜNAY, Mustafa Kemal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07604090
- Sponsor's protocol ID
- 2025/819/15-10
- Status last verified
- Jul 2026
- First submitted
- 29 Apr 2026
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be made publicly available in order to protect participant privacy and confidentiality.
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Acute Effect of Fibular Repositioning Taping on Balance, Jumping, and Sprint Performance in Healthy Individuals: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07604090
- Acronym / sponsor ID
- 2025/819/15-10
- Conditions
- Physical Performance, Balance, Taping
- Keywords
- Fibular Repositioning Taping, Sprint Performance, Balance, Jumping Performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 2 Jan 2026 (actual)
- Primary completion
- 15 May 2026 (actual)
- Study completion
- 15 May 2026 (actual)
- First posted
- 22 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to investigate the acute effects of fibular repositioning taping on balance, jumping, and sprint performance in healthy individuals. Eligible participants are randomly allocated to one of three groups: fibular repositioning taping, sham taping, or control. Physical performance and dynamic balance are assessed at baseline and after the intervention using functional outcome measures, including jumping tests, a 10-meter sprint test, and the Y Balance Test. The study is designed to determine whether fibular repositioning taping produces short-term changes in selected performance parameters compared with sham taping and no intervention.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Fibular Repositioning Taping Group | Experimental | Procedure: Fibular Repositioning TapingParticipants in this group receive fibular repositioning taping applied to the dominant ankle. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the intervention. |
| Sham Taping Group | Sham comparator | Procedure: Sham TapingParticipants in this group receive a sham taping application with a similar appearance to the fibular repositioning taping but without therapeutic fibular repositioning. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the application. |
| Control Group | No intervention | –Participants in this group receive no taping intervention. Baseline assessments are performed, and outcome measurements are repeated after a 30-minute waiting period. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Healthy individuals
- Age between 18 and 30 years
- Willingness to participate in the study and provide informed consent
- Ability to perform balance, jump, and sprint performance tests
Key exclusion criteria (5 listed)
- History of lower extremity injury or surgery within the last 6 months
- Presence of acute pain during testing
- Neurological, orthopedic, or vestibular condition that may affect balance or performance
- Previous experience of adverse reaction to taping material
- Refusal to participate or inability to complete the study procedures
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fibular Repositioning TapingFibular repositioning taping is applied to the dominant ankle using a rigid taping technique intended to support fibular positioning. Outcome measurements are repeated 30 minutes after the application. | Procedure or surgery | Fibular Repositioning Taping Group |
| Sham TapingSham taping is applied to the dominant ankle with a similar appearance to the active taping application but without therapeutic fibular repositioning or manual correction | Procedure or surgery | Sham Taping Group |
Primary outcome
Y Balance Test
Time frame: Baseline and 30 minutes after the intervention
Dynamic balance will be assessed using the Y Balance Test. The composite score will be calculated from reach distances and normalized to limb length. Higher composite scores indicate better dynamic balance performance.
Horizontal Jump Test
Time frame: Baseline and 30 minutes after the intervention
Horizontal jump performance will be assessed using the Horizontal Jump Test. The jump distance will be measured in centimeters from the starting line to the landing point. Greater distance indicates better horizontal jump performance.
10-Meter Sprint Test
Time frame: Baseline and 30 minutes after the intervention
Sprint performance will be assessed using the 10-meter sprint test. The time required to complete the 10-meter sprint will be recorded in seconds. Shorter times indicate better sprint performance.
Vertical Jump Test
Time frame: Baseline and 30 minutes after the intervention
Vertical jump performance will be assessed using the Vertical Jump Test. Jump height will be measured in centimeters. Greater jump height indicates better vertical jump performance.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be made publicly available in order to protect participant privacy and confidentiality.
Related trials for Physical Performance
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
RecruitingObservational study
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
Tricuspid Regurgitation (TR)
Not yet recruiting
Motor Imagery and Turning Practice to Improve Mobility: Pilot Trial
Mobility Impairment, Community Dwelling Older Adults
Recruiting
Acute Effects of Post-Exercise Hyperoxia on Recovery in Cycling
Athletic Performance, Hyperbaric Oxygenation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fibular Repositioning Taping in people with Physical Performance and Balance, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Y Balance Test (time frame: Baseline and 30 minutes after the intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.